Fluorescent In Situ Hybridization Probe Market Industry Forecast Reflecting Growth To $2.39 Billion By 2030

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Fluorescent In Situ Hybridization Probe Market Change Between 2026 And 2030?

The fluorescent in situ hybridization probe market size has experienced robust expansion over the past few years. This market is projected to expand from $1.68 billion in 2025 to $1.8 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to its historical growth include the limited availability of fluorescent probes, reliance on conventional single-color FISH, a rising recognition of genetic diagnostics, increased investment in molecular biology research, and the broader acceptance of fluorescence microscopy.

The fluorescent in situ hybridization probe market is projected to experience substantial expansion in the coming years. This market is forecast to reach a size of $2.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period is primarily driven by factors such as the advancement of multiplex and combinatorial barcoded probes, the growing utilization in personalized medicine, the broadening scope of pharmaceutical and biotechnology research, stricter regulatory compliance and standardization efforts, and the incorporation of AI-powered image analysis and data analytics. Key trends anticipated during the same period encompass the escalating acceptance of FISH probes in clinical diagnostics, the wider deployment of multiplex and high-throughput screening methodologies, their expanding application in genetic and agricultural research, their integration with sophisticated imaging and analysis instruments, and a heightened emphasis on crafting custom probes for tailored medical treatments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27289&type=smp

What Core Drivers Are Transforming The Fluorescent In Situ Hybridization Probe Market?

The expanding acceptance of personalized medicine is anticipated to stimulate the growth of the fluorescent in situ hybridization probe market moving forward. This medical model, known as personalized medicine, utilizes an individual’s genetic and lifestyle information to customize treatments and healthcare to their particular needs. The increasing uptake of personalized medicine is attributed to people preferring health technologies that offer real-time monitoring and treatment plans specifically adapted to their unique biology. Fluorescent in situ hybridization (FISH) probes support personalized medicine by enabling the precise identification of genetic abnormalities at the chromosomal level, thereby informing tailored therapeutic decisions based on an individual’s distinct genetic profile. For instance, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the rising adoption of personalized medicine is a key driver for the fluorescent in situ hybridization probe market’s expansion.

Which Segment Groups Define The Fluorescent In Situ Hybridization Probe Market Landscape?

The fluorescent in situ hybridization probe market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes

2) By Target: Genes, Chromosomes, Other Targets

3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies

4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research

5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes

2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes

3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes

What Trends Are Influencing The Fluorescent In Situ Hybridization Probe Market?

Major companies within the fluorescent in situ hybridization probe market are prioritizing the establishment of strategic collaborations to secure access to new markets, technologies, or expertise that would be challenging or costly to develop individually. A strategic collaboration involves a structured partnership between two or more entities that combine their strengths and resources to achieve shared long-term goals and mutual benefits. For example, in April 2025, Empire Genomics, a US-based molecular diagnostics company, partnered with BioDot, a US-based precision dispensing automation provider, to launch the BDot Probe Line. The BDot Probe Line offers a distinct solution by providing FISH probes that are pre-optimized for automated systems, directly addressing a critical challenge in clinical cytogenetics and molecular pathology laboratories. These probes are engineered for direct application without requiring manual adjustments, ensuring smooth operation with the Biodot CellWriter S system. This innovation reduces the necessity for technician intervention, streamlines laboratory workflows, and shortens the turnaround time for results. The initial suite of BDot Probe Panels supports FISH analysis for a broad spectrum of blood-related cancers, including MM, MDS, CML, AML, ALL, and other prevalent hematologic conditions.

Which Organizations Are Operating Within The Fluorescent In Situ Hybridization Probe Market?

Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., Cytocell Technologies Limited.

Access The Complete Fluorescent In Situ Hybridization Probe Market Report:

https://www.thebusinessresearchcompany.com/report/fluorescent-in-situ-hybridization-probe-global-market-report

Which Geographic Region Represents The Largest Fluorescent In Situ Hybridization Probe Market Share?

North America was the largest region in the fluorescent in situ hybridization probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Fluorescent In Situ Hybridization Probe Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/fluorescent-in-situ-hybridization-probe-global-market-report

Browse Through More Reports Similar to the Global Fluorescent In Situ Hybridization Probe Market 2026, By The Business Research Company

Motor Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report

Home Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/home-insurance-global-market-report

Embedded Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/embedded-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795